Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yuanbai Li"'
Publikováno v:
Drug Delivery, Vol 28, Iss 1, Pp 325-342 (2021)
The aim of the present study was to investigate the pharmacological mechanism of matrine in treatment of COVID-19 combined with liver injury. Potential targets related to matrine, COVID-19 and liver injury were identified from several databases. We c
Externí odkaz:
https://doaj.org/article/f61fefd5370d4c08b50e490dc3ab91c8
Publikováno v:
IOP Conference Series: Earth and Environmental Science. 1124:012108
With the rapid development of tunnelling engineering construction, especially the deep buried long tunnels, the full-face hard rock tunnel boring machines (TBMs) have been widely used in excavation process because of its significant advantages includ
Publikováno v:
Chinese Medical Sciences Journal. 37:195
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Objective To investigate the pharmacological mechanism of the iridoid glycosides from Fructus Gardeniae in Jiangxi province by network pharmacology. To provide a valuable research strategy for the rational use and in-depth research and development of
Autor:
Zafar Iqbal, Lijuan Zhai, Yuanyu Gao, Dong Tang, Xueqin Ma, Jinbo Ji, Jian Sun, Jingwen Ji, Yuanbai Liu, Rui Jiang, Yangxiu Mu, Lili He, Haikang Yang, Zhixiang Yang
Publikováno v:
Beilstein Journal of Organic Chemistry, Vol 17, Iss 1, Pp 711-718 (2021)
The diazabicyclooctane (DBO) scaffold is the backbone of non-β-lactam-based second generation β-lactamase inhibitors. As part of our efforts, we have synthesized a series of DBO derivatives A1–23 containing amidine substituents at the C2 position
Externí odkaz:
https://doaj.org/article/a15cc7d620484f53aae7a5e3d9970587
Autor:
Lili He, Lijuan Zhai, Jian Sun, Jingwen Ji, Jinbo Ji, Yuanbai Liu, Yangxiu Mu, Yuanyu Gao, Dong Tang, Rui Jiang, Ko Ko Myo, Zaw Min Thu, Haikang Yang, Zafar Iqbal, Zhixiang Yang
Publikováno v:
Journal of Chemistry, Vol 2021 (2021)
Background. Owing to the intrinsic stability against common β-lactamases and metallo-lactamases, monobactams gathered special attention in antibiotic drug development. However, so far, aztreonam is the only monobactam approved by FDA for clinical us
Externí odkaz:
https://doaj.org/article/3768f418cfc6430d8ef7d03cc4f0eea8